Search Type: drug or dietary supplement name
Search Term: colchicine (COLCRYS, MITIGARE)

Disease and Drug Family Information | Worst Pills, Best Pills Newsletter Articles

Disease and Drug Family Information

Search results below include Disease and Drug Family Information where your selected drug is a secondary subject of discussion
  • Vitamins and Minerals [hide all summaries]
    One promotional strategy of supplement suppliers is to make people worry about whether they are getting enough nutrients. But do most people really need to take vitamins and minerals to supplement their diets? Or are they a waste of money? Are there better alternatives to taking supplements to ensure adequate nutrition? This section will attempt to answer these questions and help you sort through the fact and fiction surrounding nutritional supplements.

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
  • Gout Drug Febuxostat (ULORIC): Risks Outweigh Benefits [hide all summaries]
    (May 2018)
    When the FDA approved febuxostat in 2009 for treating high uric acid blood levels in patients with gout, we advised readers not to use the drug until at least February 2016 based on our longstanding “Seven-Year Rule.” Read this article to hear results of new research that prompted us to now designate febuxostat as Do Not Use.
  • Drug Mix-Ups [hide all summaries]
    (June 2011)
    This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
  • Do Automated Screening Systems for Drug Interactions Adequately Protect You? [hide all summaries]
    (August 2009)
    Many doctors and pharmacists use computerized drug interaction screening systems to prevent the prescriptions for drugs that may have a harmful interaction with drugs already being used by the patient. This article points out several significant weaknesses of these systems and provides five common sense suggestions as to how patients can avoid dangerous drug interactions despite the weaknesses of these computerized systems.
  • Calcium Channel Blocker Drug Interactions [hide all summaries]
    (May 2008)
    This article lists more than 60 prescription drugs that can interact with calcium channel blocking drugs such as amlodipine (NORVASC),diltiazem (CARDIZEM, DILACOR XR TIAZAC)or nifedipine (PROCARDIA)to either cause toxicity or to lessen the effectiveness of the calcium channel blocking drugs. Included in the lists are a number of drugs that we list in Worst Pills, Best Pills as DO NOT USE or LIMITED USE drugs. The article also explains the different kinds of toxicity that can ensue from these interactions.
  • Macrolide Antibiotic Drug Interactions [hide all summaries]
    (February 2008)
    The article discusses the adverse drug interactions between either of two widely-prescribed macrolide antibiotics, erythromycin (as in ERYTHROCIN) and clarithromycin (BIAXIN)and more than 40 other drugs that are listed in a table in the article. It also describes the nature of the adverse interactions that can occur.

SHOW primary search results for colchicine (COLCRYS, MITIGARE)

Copyright © 2018 Public Citizen's Health Research Group. All rights reserved.